(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PKLR mRNA CTD PMID:36331819 (S)-nicotine multiple interactions ISO RGD:737364 6480464 [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of PKLR mRNA CTD PMID:28065790 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of PKLR mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of PKLR mRNA CTD PMID:28189721 , PMID:28960355 1-naphthyl isothiocyanate decreases expression ISO RGD:3336 6480464 1-Naphthylisothiocyanate results in decreased expression of PKLR mRNA CTD PMID:17522070 , PMID:25380136 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of PKLR mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of PKLR mRNA CTD PMID:24440342 17alpha-ethynylestradiol decreases expression ISO RGD:3336 6480464 Ethinyl Estradiol results in decreased expression of PKLR mRNA CTD PMID:15953391 17beta-estradiol decreases expression ISO RGD:737364 6480464 Estradiol results in decreased expression of PKLR mRNA CTD PMID:20106945 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:3336 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737364 6480464 Tetrachlorodibenzodioxin results in decreased expression of PKLR mRNA CTD PMID:20106945 , PMID:31520823 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Dietary Fats promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKLR mRNA], Tetrachlorodibenzodioxin promotes the reaction [Dietary Fats results in decreased expression of PKLR mRNA] CTD PMID:27713108 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PKLR mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PKLR mRNA CTD PMID:25975270 , PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737364 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PKLR mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:3336 6480464 Tetrachlorodibenzodioxin results in decreased expression of PKLR mRNA CTD PMID:21215274 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:3336 6480464 Tetrachlorodibenzodioxin affects the expression of PKLR mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737364 6480464 Tetrachlorodibenzodioxin affects the expression of PKLR mRNA CTD PMID:22298810 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of PKLR mRNA CTD PMID:17982090 2,4-dinitrotoluene affects expression ISO RGD:3336 6480464 2, 4-dinitrotoluene affects the expression of PKLR mRNA CTD PMID:21346803 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of PKLR mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:28973532 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:3336 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:3336 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:28973532 3-chloropropane-1,2-diol increases expression ISO RGD:3336 6480464 alpha-Chlorohydrin analog results in increased expression of PKLR protein more ... CTD PMID:26597043 , PMID:28522335 3-phenylprop-2-enal multiple interactions ISO RGD:3336 6480464 cinnamaldehyde inhibits the reaction [Streptozocin results in decreased expression of PKLR mRNA] CTD PMID:20363216 3H-1,2-dithiole-3-thione increases expression ISO RGD:3336 6480464 1, 2-dithiol-3-thione results in increased expression of PKLR mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO RGD:3336 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PKLR mRNA CTD PMID:25380136 , PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:737364 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PKLR mRNA CTD PMID:31121516 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of PKLR gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PKLR mRNA CTD PMID:30145421 4-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-6-oxo-7H-thieno[2,3-b]pyridine-5-carbonitrile multiple interactions ISO RGD:3336 6480464 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:31974165 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of PKLR mRNA CTD PMID:28973697 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:3336 6480464 Omeprazole affects the expression of PKLR mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression ISO RGD:3336 6480464 Propylthiouracil affects the expression of PKLR mRNA CTD PMID:19483382 acetamide decreases expression ISO RGD:3336 6480464 acetamide results in decreased expression of PKLR mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:737364 6480464 Aflatoxin B1 affects the expression of PKLR protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:737364 6480464 Aflatoxin B1 results in decreased expression of PKLR mRNA CTD PMID:21641981 , PMID:27153756 aflatoxin B1 multiple interactions ISO RGD:3336 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of PKLR mRNA CTD PMID:25450479 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of PKLR mRNA CTD PMID:19770486 aldehydo-D-glucose increases expression ISO RGD:3336 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:16644726 more ... aldehydo-D-glucose increases expression ISO RGD:737364 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:27226639 aldehydo-D-glucose multiple interactions ISO RGD:3336 6480464 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:16644726 , PMID:31974165 aldehydo-D-glucose increases activity ISO RGD:3336 6480464 Glucose results in increased activity of PKLR protein CTD PMID:16644726 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:17786952 aluminium atom increases activity ISO RGD:737364 6480464 Aluminum results in increased activity of PKLR protein CTD PMID:16979867 aluminium(0) increases activity ISO RGD:737364 6480464 Aluminum results in increased activity of PKLR protein CTD PMID:16979867 amiodarone affects expression ISO RGD:3336 6480464 Amiodarone affects the expression of PKLR mRNA CTD PMID:19483382 ammonium chloride affects expression ISO RGD:3336 6480464 Ammonium Chloride affects the expression of PKLR mRNA CTD PMID:16483693 aristolochic acid A multiple interactions ISO RGD:3336 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of PKLR mRNA CTD PMID:23912714 arsane affects methylation ISO RGD:737364 6480464 Arsenic affects the methylation of PKLR gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:737364 6480464 Arsenic affects the methylation of PKLR gene CTD PMID:25304211 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PKLR mRNA CTD PMID:30362509 arsenous acid multiple interactions EXP 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PKLR mRNA] CTD PMID:30362509 atorvastatin calcium multiple interactions ISO RGD:3336 6480464 Atorvastatin inhibits the reaction [Fructose results in increased expression of PKLR mRNA] CTD PMID:19053045 , PMID:21122807 atrazine multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of PKLR mRNA CTD PMID:24440342 atrazine increases expression ISO RGD:737364 6480464 Atrazine results in increased expression of PKLR mRNA CTD PMID:25275270 benzbromarone affects expression ISO RGD:3336 6480464 Benzbromarone affects the expression of PKLR mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PKLR mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene decreases methylation ISO RGD:737364 6480464 Benzo(a)pyrene results in decreased methylation of PKLR promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:737364 6480464 Benzo(a)pyrene results in decreased expression of PKLR mRNA CTD PMID:20106945 , PMID:32234424 bicalutamide decreases expression ISO RGD:3336 6480464 bicalutamide results in decreased expression of PKLR protein CTD PMID:35151640 bifenthrin decreases expression EXP 6480464 bifenthrin results in decreased expression of PKLR mRNA CTD PMID:26071804 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PKLR mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of PKLR mRNA CTD PMID:19245819 , PMID:19850644 bisphenol A decreases expression ISO RGD:3336 6480464 bisphenol A results in decreased expression of PKLR mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PKLR mRNA CTD PMID:34585602 bisphenol A decreases expression ISO RGD:737364 6480464 bisphenol A results in decreased expression of PKLR protein CTD PMID:33376534 bosentan affects expression ISO RGD:737364 6480464 Bosentan affects the expression of PKLR mRNA CTD PMID:29761207 bromobenzene decreases expression ISO RGD:3336 6480464 bromobenzene results in decreased expression of PKLR mRNA CTD PMID:32479839 buspirone decreases expression ISO RGD:3336 6480464 Buspirone results in decreased expression of PKLR mRNA CTD PMID:24136188 cadmium dichloride decreases expression ISO RGD:3336 6480464 Cadmium Chloride results in decreased expression of PKLR mRNA CTD PMID:25993096 calcium atom multiple interactions ISO RGD:3336 6480464 Calcium inhibits the reaction [Phenylephrine results in decreased activity of PKLR protein] CTD PMID:747652 calcium(0) multiple interactions ISO RGD:3336 6480464 Calcium inhibits the reaction [Phenylephrine results in decreased activity of PKLR protein] CTD PMID:747652 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 chlorothalonil multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PKLR mRNA CTD PMID:33246813 chlorothalonil decreases expression EXP 6480464 tetrachloroisophthalonitrile results in decreased expression of PKLR mRNA CTD PMID:33246813 cholesterol multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of PKLR mRNA more ... CTD PMID:24440342 choline multiple interactions EXP 6480464 3 more ... CTD PMID:28973532 clofibrate affects expression ISO RGD:3336 6480464 Clofibrate affects the expression of PKLR mRNA CTD PMID:19483382 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of PKLR mRNA CTD PMID:17585979 , PMID:30629241 clofibrate decreases expression ISO RGD:3336 6480464 Clofibrate results in decreased expression of PKLR mRNA, Clofibrate results in decreased expression of PKLR protein CTD PMID:16470657 more ... cobalt dichloride decreases expression ISO RGD:3336 6480464 cobaltous chloride results in decreased expression of PKLR mRNA CTD PMID:24386269 copper atom decreases expression ISO RGD:3336 6480464 Copper results in decreased expression of PKLR mRNA CTD PMID:22465980 copper(0) decreases expression ISO RGD:3336 6480464 Copper results in decreased expression of PKLR mRNA CTD PMID:22465980 cyclosporin A decreases expression ISO RGD:3336 6480464 Cyclosporine results in decreased expression of PKLR mRNA CTD PMID:19224547 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PKLR mRNA CTD PMID:23830897 cyclosporin A decreases expression ISO RGD:737364 6480464 Cyclosporine results in decreased expression of PKLR mRNA CTD PMID:20106945 , PMID:23830897 cypermethrin multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with cypermethrin] results in increased expression of PKLR mRNA CTD PMID:24440342 D-glucose increases expression EXP 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:17786952 D-glucose increases expression ISO RGD:737364 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:27226639 D-glucose increases expression ISO RGD:3336 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:16644726 more ... D-glucose increases activity ISO RGD:3336 6480464 Glucose results in increased activity of PKLR protein CTD PMID:16644726 D-glucose multiple interactions ISO RGD:3336 6480464 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:16644726 , PMID:31974165 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PKLR mRNA CTD PMID:29950665 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PKLR mRNA CTD PMID:30362509 diarsenic trioxide multiple interactions EXP 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PKLR mRNA] CTD PMID:30362509 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:3336 6480464 Dibutyl Phthalate results in increased expression of PKLR mRNA CTD PMID:21266533 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of PKLR mRNA CTD PMID:26934552 diethyl maleate decreases expression ISO RGD:3336 6480464 diethyl maleate results in decreased expression of PKLR mRNA CTD PMID:21161181 dihydroxyacetone multiple interactions ISO RGD:3336 6480464 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2, 3-b)pyridine-5-carbonitrile inhibits the reaction [Dihydroxyacetone results in increased expression of PKLR mRNA] CTD PMID:31974165 Diosbulbin B increases expression EXP 6480464 diosbulbin B results in increased expression of PKLR mRNA CTD PMID:32148032 disodium selenite multiple interactions EXP 6480464 Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PKLR mRNA] CTD PMID:26522834 duvoglustat multiple interactions EXP 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PKLR protein] CTD PMID:25446853 endosulfan multiple interactions ISO RGD:737364 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PKLR mRNA CTD PMID:26159488 endosulfan decreases expression ISO RGD:737364 6480464 Endosulfan results in decreased expression of PKLR mRNA CTD PMID:31520823 endosulfan decreases expression ISO RGD:3336 6480464 Endosulfan results in decreased expression of PKLR mRNA CTD PMID:29391264 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of PKLR mRNA CTD PMID:35436446 erythromycin estolate decreases expression ISO RGD:3336 6480464 Erythromycin Estolate results in decreased expression of PKLR mRNA CTD PMID:17522070 ethanol multiple interactions EXP 6480464 Ethanol inhibits the reaction [Fish Oils results in decreased expression of PKLR mRNA], pirinixic acid inhibits the reaction [Ethanol results in increased expression of PKLR mRNA] CTD PMID:18620774 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PKLR mRNA CTD PMID:18620774 , PMID:19167417 fenofibrate decreases expression ISO RGD:737364 6480464 Fenofibrate results in decreased expression of PKLR mRNA CTD PMID:25572481 fenthion increases expression EXP 6480464 Fenthion results in increased expression of PKLR mRNA CTD PMID:34813904 flavonoids decreases expression ISO RGD:3336 6480464 Flavonoids results in decreased expression of PKLR mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PKLR mRNA CTD PMID:17702527 flutamide increases expression ISO RGD:3336 6480464 Flutamide results in increased expression of PKLR mRNA CTD PMID:24136188 fructose increases expression EXP 6480464 Fructose results in increased expression of PKLR mRNA CTD PMID:17786952 , PMID:28123933 fructose increases expression ISO RGD:3336 6480464 Fructose results in increased expression of PKLR mRNA CTD PMID:18346472 more ... fructose multiple interactions ISO RGD:3336 6480464 Atorvastatin inhibits the reaction [Fructose results in increased expression of PKLR mRNA], GCG protein affects the reaction [Fructose affects the degradation of PKLR mRNA] CTD PMID:19053045 more ... fructose affects expression ISO RGD:3336 6480464 Fructose affects the expression of PKLR mRNA CTD PMID:6759123 fructose affects degradation ISO RGD:3336 6480464 Fructose affects the degradation of PKLR mRNA CTD PMID:2414297 fructose multiple interactions EXP 6480464 FGF21 gene mutant form inhibits the reaction [Fructose results in increased expression of PKLR mRNA], lactisole inhibits the reaction [Fructose results in increased expression of PKLR mRNA] CTD PMID:17786952 , PMID:28123933 furan increases methylation ISO RGD:3336 6480464 furan results in increased methylation of PKLR gene CTD PMID:22079235 gentamycin decreases expression ISO RGD:3336 6480464 Gentamicins results in decreased expression of PKLR mRNA CTD PMID:22061828 glucose increases expression EXP 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:17786952 glucose increases expression ISO RGD:737364 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:27226639 glucose increases expression ISO RGD:3336 6480464 Glucose results in increased expression of PKLR mRNA CTD PMID:16644726 more ... glucose increases activity ISO RGD:3336 6480464 Glucose results in increased activity of PKLR protein CTD PMID:16644726 glucose multiple interactions ISO RGD:3336 6480464 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:16644726 , PMID:31974165 glyburide multiple interactions ISO RGD:3336 6480464 Glyburide inhibits the reaction [Streptozocin results in decreased expression of PKLR mRNA] CTD PMID:20363216 glycerol increases expression ISO RGD:3336 6480464 Glycerol results in increased expression of PKLR mRNA CTD PMID:2193023 glycerol multiple interactions ISO RGD:737364 6480464 [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of PKLR mRNA CTD PMID:28065790 hexadecanoic acid multiple interactions ISO RGD:737364 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PKLR mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of PKLR mRNA CTD PMID:30547786 hydroxyurea decreases expression EXP 6480464 Hydroxyurea results in decreased expression of PKLR mRNA CTD PMID:12929121 isotretinoin decreases expression ISO RGD:737364 6480464 Isotretinoin results in decreased expression of PKLR mRNA CTD PMID:20436886 L-ethionine affects expression ISO RGD:3336 6480464 Ethionine affects the expression of PKLR mRNA CTD PMID:19483382 L-methionine multiple interactions EXP 6480464 3 more ... CTD PMID:28973532 Lasiocarpine decreases expression ISO RGD:737364 6480464 lasiocarpine results in decreased expression of PKLR mRNA CTD PMID:32234424 leflunomide decreases expression ISO RGD:3336 6480464 leflunomide results in decreased expression of PKLR mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:737364 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PKLR mRNA CTD PMID:35811015 metformin increases expression ISO RGD:3336 6480464 Metformin results in increased expression of PKLR mRNA CTD PMID:31324951 metformin multiple interactions ISO RGD:3336 6480464 Metformin inhibits the reaction [Glucose results in increased expression of PKLR mRNA] CTD PMID:31974165 methapyrilene increases expression ISO RGD:3336 6480464 Methapyrilene results in increased expression of PKLR mRNA CTD PMID:22484513 methapyrilene decreases expression ISO RGD:3336 6480464 Methapyrilene results in decreased expression of PKLR mRNA CTD PMID:28903497 monosodium L-glutamate increases expression ISO RGD:3336 6480464 Sodium Glutamate results in increased expression of PKLR mRNA CTD PMID:26092479 N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide multiple interactions EXP 6480464 N-(3, 5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Particulate Matter results in increased expression of PKLR mRNA] CTD PMID:29635361 N-nitrosodiethylamine multiple interactions ISO RGD:3336 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of PKLR mRNA CTD PMID:28943392 N-nitrosodimethylamine decreases expression ISO RGD:3336 6480464 Dimethylnitrosamine results in decreased expression of PKLR mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:737364 6480464 N-Nitrosopyrrolidine results in decreased expression of PKLR mRNA CTD PMID:32234424 naloxone decreases expression ISO RGD:3336 6480464 Naloxone results in decreased expression of PKLR mRNA CTD PMID:17522070 nefazodone decreases expression ISO RGD:3336 6480464 nefazodone results in decreased expression of PKLR mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:737364 6480464 Nickel results in decreased expression of PKLR mRNA CTD PMID:24768652 nicotine multiple interactions ISO RGD:737364 6480464 [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of PKLR mRNA CTD PMID:28065790 nimesulide decreases expression ISO RGD:3336 6480464 nimesulide results in decreased expression of PKLR mRNA CTD PMID:24136188 nitrofen increases expression ISO RGD:3336 6480464 nitrofen results in increased expression of PKLR mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:737364 6480464 methyleugenol results in decreased expression of PKLR mRNA CTD PMID:32234424 ochratoxin A decreases expression ISO RGD:3336 6480464 ochratoxin A results in decreased expression of PKLR mRNA CTD PMID:16251485 octadecanoic acid decreases expression ISO RGD:737364 6480464 stearic acid results in decreased expression of PKLR protein CTD PMID:26739624 oleic acid multiple interactions ISO RGD:737364 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PKLR mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of PKLR mRNA CTD PMID:30547786 omeprazole affects expression ISO RGD:3336 6480464 Omeprazole affects the expression of PKLR mRNA CTD PMID:19483382 oxaliplatin multiple interactions ISO RGD:3336 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PKLR mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:3336 6480464 oxaliplatin results in decreased expression of PKLR mRNA CTD PMID:25729387 ozone increases expression ISO RGD:3336 6480464 Ozone results in increased expression of PKLR mRNA CTD PMID:25838073 p-anisidine decreases expression EXP 6480464 4-anisidine results in decreased expression of PKLR mRNA CTD PMID:12929121 p-toluidine decreases expression ISO RGD:3336 6480464 4-toluidine results in decreased expression of PKLR mRNA CTD PMID:27638505 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of PKLR mRNA CTD PMID:12929121 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PKLR mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PKLR mRNA CTD PMID:29246445 paracetamol multiple interactions EXP 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of PKLR mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:737364 6480464 Acetaminophen results in decreased expression of PKLR mRNA CTD PMID:22230336 more ... paracetamol decreases expression ISO RGD:3336 6480464 Acetaminophen results in decreased expression of PKLR mRNA CTD PMID:17202762 , PMID:17522070 PCB138 decreases expression ISO RGD:3336 6480464 2 more ... CTD PMID:23829299 penconazole decreases expression EXP 6480464 penconazole results in decreased expression of PKLR mRNA CTD PMID:31733957 perfluorononanoic acid decreases expression ISO RGD:737364 6480464 perfluoro-n-nonanoic acid results in decreased expression of PKLR mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of PKLR mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PKLR mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:737364 6480464 perfluorooctane sulfonic acid results in decreased expression of PKLR mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:3336 6480464 perfluorooctane sulfonic acid results in decreased expression of PKLR mRNA CTD PMID:19162173 , PMID:21723365 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of PKLR mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:737364 6480464 perfluorooctanoic acid results in decreased expression of PKLR mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PKLR mRNA CTD PMID:20118188 , PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:3336 6480464 perfluorooctanoic acid results in decreased expression of PKLR mRNA, perfluorooctanoic acid results in decreased expression of PKLR protein CTD PMID:19162173 more ... perfluorooctanoic acid multiple interactions EXP 6480464 [perfluorooctanoic acid co-treated with Dietary Fats more ... CTD PMID:20118188 , PMID:23626681 permethrin decreases expression EXP 6480464 Permethrin results in decreased expression of PKLR mRNA CTD PMID:30629241 phenformin decreases expression ISO RGD:3336 6480464 Phenformin results in decreased expression of PKLR mRNA CTD PMID:31324951 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PKLR mRNA] CTD PMID:19482888 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PKLR mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PKLR mRNA CTD PMID:19270015 , PMID:19482888 phenobarbital decreases expression ISO RGD:3336 6480464 Phenobarbital results in decreased expression of PKLR mRNA CTD PMID:19162173 phenylephrine multiple interactions ISO RGD:3336 6480464 Calcium inhibits the reaction [Phenylephrine results in decreased activity of PKLR protein] CTD PMID:747652 phenylephrine decreases activity ISO RGD:3336 6480464 Phenylephrine results in decreased activity of PKLR protein CTD PMID:747652 piperonyl butoxide decreases expression ISO RGD:3336 6480464 Piperonyl Butoxide results in decreased expression of PKLR mRNA CTD PMID:22484513 pirinixic acid multiple interactions ISO RGD:737364 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PKLR mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PKLR mRNA CTD PMID:16807375 more ... pirinixic acid decreases expression ISO RGD:3336 6480464 pirinixic acid results in decreased expression of PKLR mRNA CTD PMID:16644726 more ... pirinixic acid affects expression ISO RGD:3336 6480464 pirinixic acid affects the expression of PKLR mRNA CTD PMID:19483382 pirinixic acid multiple interactions ISO RGD:3336 6480464 MLXIPL protein inhibits the reaction [pirinixic acid results in decreased expression of PKLR mRNA] more ... CTD PMID:16644726 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of PKLR mRNA more ... CTD PMID:18620774 more ... pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:3336 6480464 Pregnenolone Carbonitrile results in decreased expression of PKLR mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of PKLR mRNA CTD PMID:28903501 procymidone multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PKLR mRNA CTD PMID:33246813 procymidone decreases expression EXP 6480464 procymidone results in decreased expression of PKLR mRNA CTD PMID:33246813 propamocarb decreases expression EXP 6480464 propamocarb results in decreased expression of PKLR mRNA CTD PMID:29137890 propane-1,2-diol multiple interactions ISO RGD:737364 6480464 [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of PKLR mRNA CTD PMID:28065790 propiconazole decreases expression ISO RGD:3336 6480464 propiconazole results in decreased expression of PKLR mRNA CTD PMID:19423681 Propiverine affects binding ISO RGD:3336 6480464 propiverine binds to PKLR protein CTD PMID:29273565 prostaglandin E2 decreases expression EXP 6480464 Dinoprostone results in decreased expression of PKLR mRNA CTD PMID:10357836 quinidine decreases expression ISO RGD:3336 6480464 Quinidine results in decreased expression of PKLR mRNA CTD PMID:17522070 resveratrol multiple interactions ISO RGD:737364 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PKLR mRNA CTD PMID:23557933 rifampicin increases expression ISO RGD:737364 6480464 Rifampin results in increased expression of PKLR mRNA CTD PMID:24552687 rotenone decreases expression ISO RGD:3336 6480464 Rotenone results in decreased expression of PKLR mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737364 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PKLR mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:737364 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of PKLR mRNA CTD PMID:35811015 silver atom increases expression EXP 6480464 Silver results in increased expression of PKLR mRNA CTD PMID:27131904 silver(0) increases expression EXP 6480464 Silver results in increased expression of PKLR mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:737364 6480464 sodium arsenite results in decreased expression of PKLR mRNA CTD PMID:17879257 , PMID:29301061 sodium arsenite decreases expression ISO RGD:3336 6480464 sodium arsenite results in decreased expression of PKLR mRNA CTD PMID:35314868 sodium arsenite increases expression ISO RGD:3336 6480464 sodium arsenite results in increased expression of PKLR protein CTD PMID:29459688 sodium arsenite increases expression ISO RGD:737364 6480464 sodium arsenite results in increased expression of PKLR mRNA CTD PMID:23648393 sodium dichromate decreases expression ISO RGD:3336 6480464 sodium bichromate results in decreased expression of PKLR mRNA CTD PMID:25993096 streptozocin multiple interactions ISO RGD:3336 6480464 cinnamaldehyde inhibits the reaction [Streptozocin results in decreased expression of PKLR mRNA], Glyburide inhibits the reaction [Streptozocin results in decreased expression of PKLR mRNA] CTD PMID:20363216 streptozocin multiple interactions EXP 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PKLR protein] more ... CTD PMID:25446853 , PMID:26522834 streptozocin decreases expression ISO RGD:3336 6480464 Streptozocin results in decreased expression of PKLR mRNA CTD PMID:20363216 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PKLR mRNA CTD PMID:26378955 sucrose multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of PKLR mRNA more ... CTD PMID:24440342 sulforaphane multiple interactions ISO RGD:3336 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of PKLR mRNA CTD PMID:25450479 sulprostone decreases expression EXP 6480464 sulprostone results in decreased expression of PKLR mRNA CTD PMID:10357836 suxibuzone decreases activity ISO RGD:3336 6480464 suxibuzone results in decreased activity of PKLR protein CTD PMID:3107799 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of PKLR mRNA CTD PMID:25123088 tamoxifen decreases expression ISO RGD:3336 6480464 Tamoxifen results in decreased expression of PKLR mRNA CTD PMID:19224547 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of PKLR mRNA CTD PMID:17555576 , PMID:20937368 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PKLR mRNA] CTD PMID:30362509 tetrachloromethane decreases expression ISO RGD:3336 6480464 Carbon Tetrachloride results in decreased expression of PKLR mRNA CTD PMID:17522070 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PKLR mRNA CTD PMID:31919559 tetrachloromethane increases methylation ISO RGD:3336 6480464 Carbon Tetrachloride results in increased methylation of PKLR promoter CTD PMID:30690589 tetracycline decreases expression ISO RGD:3336 6480464 Tetracycline results in decreased expression of PKLR mRNA CTD PMID:17522070 , PMID:19224547 thapsigargin increases expression ISO RGD:3336 6480464 Thapsigargin results in increased expression of PKLR protein CTD PMID:35544339 theophylline decreases expression ISO RGD:3336 6480464 Theophylline results in decreased expression of PKLR mRNA CTD PMID:17522070 thioacetamide affects expression ISO RGD:3336 6480464 Thioacetamide affects the expression of PKLR mRNA CTD PMID:19483382 thioacetamide multiple interactions ISO RGD:3336 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of PKLR mRNA CTD PMID:28943392 thioacetamide decreases expression ISO RGD:3336 6480464 Thioacetamide results in decreased expression of PKLR mRNA CTD PMID:23411599 more ... titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PKLR mRNA CTD PMID:29950665 topotecan decreases expression ISO RGD:3336 6480464 Topotecan results in decreased expression of PKLR mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:3336 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PKLR mRNA CTD PMID:25729387 triadimefon decreases expression ISO RGD:3336 6480464 triadimefon results in decreased expression of PKLR mRNA CTD PMID:19423681 trichloroethene decreases expression ISO RGD:3336 6480464 Trichloroethylene results in decreased expression of PKLR mRNA CTD PMID:33387578 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of PKLR mRNA CTD PMID:32835833 Triptolide decreases expression ISO RGD:3336 6480464 triptolide results in decreased expression of PKLR mRNA CTD PMID:23639586 triptonide increases expression EXP 6480464 triptonide results in increased expression of PKLR mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:3336 6480464 troglitazone results in decreased expression of PKLR protein CTD PMID:21315101 troglitazone decreases expression ISO RGD:737364 6480464 troglitazone results in decreased expression of PKLR mRNA CTD PMID:25572481 urethane decreases expression ISO RGD:737364 6480464 Urethane results in decreased expression of PKLR mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression ISO RGD:3336 6480464 Ursodeoxycholic Acid results in decreased expression of PKLR mRNA CTD PMID:15885361 valdecoxib decreases expression ISO RGD:3336 6480464 valdecoxib results in decreased expression of PKLR mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:737364 6480464 Valproic Acid results in increased methylation of PKLR gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:3336 6480464 Valproic Acid results in decreased expression of PKLR mRNA CTD PMID:19224547 valproic acid decreases expression ISO RGD:737364 6480464 Valproic Acid results in decreased expression of PKLR mRNA, Valproic Acid results in decreased expression of PKLR protein CTD PMID:29154799 , PMID:29501571